ArrayPatch Ltd Secures $1.5 Million in Funding for Revolutionary Microneedle Technology

ArrayPatch Ltd, a pioneering pre-revenue and preclinical spin-out from University College Cork, has successfully raised €1,500,000 in a recent funding round.

This significant investment will bolster the company's mission to deliver superior treatment options for healthcare professionals, ultimately enhancing patient outcomes and redefining the landscape of dermatological therapies.

At the heart of ArrayPatch's innovative approach is their groundbreaking DerMap technology, a unique microneedle system designed to improve drug delivery and absorption.

The company’s first product, aiming to treat the common yet often overlooked fungal infection of the nail, is poised to make a substantial impact in the field of dermatology.

With this influx of capital, ArrayPatch will not only advance the development of their initial offering but will also accelerate pipeline projects targeting critical areas such as skin cancer, psoriasis, and hormone replacement therapy.

The funding enables the team to conduct essential research and clinical trials, fostering a deeper understanding of the DerMap technology’s potential application.

ArrayPatch is committed to engaging healthcare professionals in the development process, ensuring that their products meet the real-world needs of both providers and patients.

As they move forward, ArrayPatch Ltd stands at the forefront of innovation in healthcare, with this funding marking a pivotal step towards achieving their vision of improved patient care and outcomes through advanced treatment technologies.